AIM ImmunoTech prices USD 2.4 million registered direct offering at USD 0.33/share

AIM ImmunoTech Inc. Common Stock

AIM ImmunoTech Inc. Common Stock

AIM

0.00
  • AIM ImmunoTech priced a $2.4 million registered direct offering of 7,519,351 common shares, or common stock equivalents, at USD 0.33 per share.
  • A concurrent private placement will issue unregistered Series I warrants to buy up to 15,038,702 shares at an exercise price of USD 0.33, subject to stockholder approval.
  • The Series I warrants expire five years from the initial exercise date.
  • Closing is expected on or about May 21, 2026.
  • Proceeds are earmarked for clinical drug supply manufacturing, planned Phase 3 trial activities, and working capital.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605201502PRIMZONEFULLFEED9724144) on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.